Connection

Jonathan Halford to Cannabidiol

Back to Details
This is a "connection" page, showing publications Jonathan Halford has written about Cannabidiol.
Jonathan Halford
Connection Strength
0.514
Cannabidiol
  1. Add-on cannabidiol in patients with Dravet syndrome: Results of a long-term open-label extension trial. Epilepsia. 2021 10; 62(10):2505-2517.
    View in: PubMed
    Score: 0.181
  2. Long-term safety and efficacy of add-on cannabidiol in patients with Lennox-Gastaut syndrome: Results of a long-term open-label extension trial. Epilepsia. 2021 09; 62(9):2228-2239.
    View in: PubMed
    Score: 0.180
  3. Cannabidiol in patients with Lennox-Gastaut syndrome: Interim analysis of an open-label extension study. Epilepsia. 2019 03; 60(3):419-428.
    View in: PubMed
    Score: 0.152
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.